Statistical methods to analyze adverse events data of randomized clinical trials

Journal of Biopharmaceutical Statistics

Volumn 19, Issue 5, 2009, Pages 889-899

  Siddiqui, Ohidul ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Adverse events; AEs; Gender; ISS; MCF

Indexed keywords

PLACEBO;

ADVERSE DRUG REACTION; ARTICLE; CARDIOVASCULAR DISEASE; DATA ANALYSIS; DRUG SAFETY; EXPOSURE; FOOD AND DRUG ADMINISTRATION; GENDER; INCIDENCE; MEAN CUMULATIVE FUNCTION; NONPARAMETRIC TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STATISTICS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOVASCULAR DISEASES; CONSUMER PRODUCT SAFETY; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; INCIDENCE; MALE; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 75149190882     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903105463     Document Type: Article

References (11)

1. Berry, S. M., Berry, D. A. (2004). Accounting for multiplicities in assessing drug safety: a three-level hierarchical mixture model. Biometrics 60(2):418-426.
2. Cook, R. J., Lawless, J. F. (1997). Marginal analysis of recurrent events and a terminating event. Stat. Med. 16:911-924.
3. Christian, M. S. (2001). Introduction/overview: Gender-based differences in pharmacologic and toxicologic responses. Int. J. Toxicol. 20:145-148.
4. Chuang-Stein, C. (1998). Safety analysis in controlled clinical trials. Drug Information J. 32:1363S-1372S.
5. General Accounting Office (GAO). (2001). Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women. Draft Report 01-286. Washington, DC: GAO.
6. Liu, G. F., Wang, J., Liu, K., Snavely, D. (2006). Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials. Stat. Med. 25(8):1275-1286.
7. Nelson, W. B. (2003). Recurrent Events Data Analysis for Product Repairs, Disease Recurrences, and Other Applications. American Statistical Association and the Society for Industrial and Applied Mathematics.
8. O'Neill, R. T. (1987). Statistical analyses of adverse event data from clinical trials, special emphasis on serious events. Drug Information J. 21:9-20.
9. O'Neill, R. T. (1995). Statistical concepts in the planning and evaluation of drug safety from clinical trials in drug development: Issues on international harmonisation. Stat. Med. 14:1117-1127.
10. Rosenkranz, G. (2006). Analysis of adverse events in the presence of discontinuations. Drug Information J. 40(01):79-87.
11. Wang, M. C., Qin, J., Chiang, C. T. (2001). Analyzing recurrent events data with informative censoring. J. Am. Stat. Assoc. 96:1057-1065.